Biocept, Inc. Closes $10 Million Term Loan Facility With Oxford Finance LLC
"The additional capital from
The initial
"We are pleased to have developed a partnership with
About
About
Forward-Looking Statements Disclaimer Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. To the extent that statements in this release are not strictly historical, including without limitation statements as to anticipated uses of the facility proceeds, our anticipated growth, the anticipated development
of our technology platform, and our ability to achieve revenue milestones, and our ability to improve the quality of cancer care while reducing patient costs, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our
CONTACT: Investor Contact:Source:The Ruth Group David Burke (646) 536-7009 dburke@theruthgroup.com Media Contact:The Ruth Group Melanie Sollid-Penton (646) 536-7023 msollid@theruthgroup.com
News Provided by Acquire Media